Keytruda Set to Become World’s Top-Selling Drug, Forecast Shows

While Humira being the top-selling drug is on the decline due to increased competition and expiring patents, another drug is set to take the number-one position. With the continued regulatory wins, it should be no surprise that Merck’s Keytruda is poised to assume the best-selling drug mantle.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *